Lonza Publishes Invitation to the 2024 Annual General Meeting and 2023 Annual and Sustainability Reports
Annual General Meeting will take place on 8 May 2024 at the Congress Center in Basel, Switzerland Albert M. Baehny will…
Annual General Meeting will take place on 8 May 2024 at the Congress Center in Basel, Switzerland Albert M. Baehny will…
Wolfgang Wienand, currently CEO of Swiss CDMO Siegfried Holding AG, will become Chief Executive Officer of Lonza in the…
CEO Pierre-Alain Ruffieux to leave Lonza Albert M. Baehny to step in as CEO ad interim Capital Markets Day on October 17…
TÜV SÜD Schweiz AG has acquired the process safety laboratory of Lonza Ltd. at its Visp site, Switzerland. By expanding…
Die TÜV SÜD Schweiz AG hat das Labor für Prozesssicherheit der Lonza AG am Standort Visp in der Schweiz übernommen. Durc…
Das Düsseldorfer Biotech-Unternehmen LenioBio GmbH hat bekannt gegeben, dass sein Gründer und Geschäftsführer, Herr Dr.…
Dr Boris Gorella appointed CEO Cinven assumes ownership Master Builders Solutions welcomes Cinven as its new owner tod…
Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates…
Daniel Palmacci joins Lonza as President of the Cell & Gene Division and member of the Executive Committee Daniel will c…
. Lonza appoints Maria Soler Nunez as Head, Group Operations Maria joins Lonza from Novartis where she has led the qua…